Inhibition of a Myotoxic Phospholipase A2 isolated from Crotalus durissus cumanensis by Pentacyclic Triterpenes
DOI:
https://doi.org/10.17533/udea.vitae.v32n1a356555Keywords:
Phospholipase A2, triterpenic compounds, molecular docking, snake venom, Crotalus durissus cumanensisAbstract
BACKGROUND: Ophidian accidents have been recognized as public health events in Colombia since 2004 and have been systematically reported since 2007, constituting a significant public health problem. One of the components present in the venoms of Viperidae snakes is the phospholipase A2 (PLA2) enzyme, playing a fundamental role in snakebite poisoning and responsible for many of the local effects that are not neutralized by antivenoms, the only treatment approved for the management of these accidents. Traditional herbal treatments hold promise, with ethnopharmacological studies emphasizing compounds, particularly pentacyclic triterpenes, as potential inhibitors of PLA2.
OBJECTIVE: To identify compounds with the potential to reduce or neutralize the local effects generated by PLA2, present in the venom of snakes of the Viperidae family, the major cause of ophidian accidents in Colombia.
METHODS: Four triterpenic compounds (madecassic acid, ursolic acid, betulinic acid, and oleanolic acid) were evaluated to determine the inhibitory capacity on the enzymatic activity of myotoxic phospholipase A2, extracted from Crotalus durissus cumanensis venom and purified by RP-HPLC. To determine the inhibitory capacity of the compounds against the enzymatic activity of PLA2, the synthetic monodisperse substrate 4-nitro-3- (octanoloxy) benzoic acid was used. Molecular docking was also performed to identify by visual inspection the interactions between the compounds and the active site of the enzyme.
RESULTS: The highest percentage of inhibition was presented by ursolic acid (47.01%). This is supported by the results of the molecular docking, where this compound was found to have interactions with Leu2, Phe24, Tyr52, and Lys69, amino acids involved in the catalytic activity of the enzyme.
CONCLUSIONS: Ursolic acid was determined as the most promising compound among the four evaluated against the local effects generated by PLA2. Future studies may be performed to determine other potential benefits of these compounds versus other biological actions of the enzyme.
Downloads
References
MinSalud, INS, Protocolo de Vigilancia en Salud Pública: Accidente ofídico. https://www.ins.gov.co/buscador/Lineamientos/PRO%20Accidente%20ofidico_.pdf 2017 (accessed 8 September 2023).
MinSalud, INS, Protocolo de Vigilancia de Accidente ofídico. https://www.ins.gov.co/buscador-eventos/Lineamientos/Pro_Accidente%20Of%C3%ADdico.pdf 2022 (accessed 8 September 2023).
INS, Sistema Nacional de Vigilancia en Salud Pública -SIVIGILA. Accidente ofídico. Periodo epidemiológico 13 - 2023. https://app.powerbi.com/view?r=eyJrIjoiMjI2MjAzYjYtMzE5YS00MmM1LTk1ZGEtOTUxYjFiNjlhZjNmIiwidCI6ImE2MmQ2YzdiLTlmNTktNDQ2OS05MzU5LTM1MzcxNDc1OTRiYiIsImMiOjR9 2023 (accessed 16 February 2024).
Sarmiento Acuña K. Aspectos biomédicos del accidente ofídico. Universitas Médica. 2012;53(1):68–85. DOI: https://doi.org/10.11144/Javeriana.umed53-1.abao
Salvador GHM, Florença Cardoso F, Gomes AA, Cavalcante WLG, Gallacci M, Fontes MRM. Search for efficient inhibitors of myotoxic activity induced by ophidian phospholipase A2-like proteins using functional, structural and bioinformatics approaches. Scientific Reports. 2019;9(510). DOI: http://doi.org/10.1038/s41598-018-36839-6
Cardoso FF, Gomes AA, Dreyer TR, Cavalcante WLG, Pai MD, Gallacci M, et al. Neutralization of a bothropic PLA2-like protein by caftaric acid, a novel potent inhibitor of ophidian myotoxicity. Biochimie. 2020;170:163–72. DOI: https://doi.org/10.1016/j.biochi.2020.01.010
Pereañez JA, Patiño AC, Henao-Castañeda IC. Toxinas provenientes de venenos de serpientes: blancos terapéuticos, herramientas en investigación biomédica y agentes con potencial terapéutico. Curare. 2014;1(1):49–60. DOI: https://doi.org/10.16925/cu.v1i1.308
Kang TS, Georgieva D, Genov N, Murakami MT, Sinha M, Kumar RP, et al. Enzymatic toxins from snake venom: structuralcharacterization and mechanism of catalysis. FEBS Journal. 2011;278:4544–76. DOI: https://doi.org/10.1111/j.1742-4658.2011.08115.x
Carvalho BMA, Santos JDL, Xavier BM, Almeida JR, Resende LM, Martins W, et al. Snake Venom PLA2s Inhibitors Isolated from Brazilian Plants: Synthetic and Natural Molecules. BioMed Research International. 2013;2013. DOI: https://doi.org/10.1155/2013/153045
Pereañez JA, Patiño AC, Núñez V, Osorio E. The biflavonoid morelloflavone inhibits the enzymatic and biological activities of a snake venom phospholipase A2. Chemico-Biological Interactions. 2014;220:94–101. DOI: http://doi.org/10.1016/j.cbi.2014.06.015
Samkumar RA, Premnath D, Raj RSDP. Strategy for early callus induction and identifcation of anti‑snake venom triterpenoids from plant extracts and suspension culture of Euphorbia hirta L. 3 Biotech. 2019;9:266. DOI: https://doi.org/10.1007/s13205-019-1790-9
Bernard P, Scior T, Didier B, Hibert M, Berthon JY. Ethnopharmacology and bioinformatic combination for leads discovery: application to phospholipase A2 inhibitors. Phytochemistry. 2001;58(6):865–74. DOI: https://doi.org/10.1016/S0031-9422(01)00312-0
Khan MF, Nahar N, Rashid RB, Chowdhury A, Rashid MA. Computational investigations of physicochemical, pharmacokinetic, toxicological properties and molecular docking of betulinic acid, a constituent of Corypha taliera (Roxb.) with Phospholipase A2 (PLA2). BMC Complementary and Alternative Medicine. 2018;18(48). DOI: https://doi.org/10.1186/s12906-018-2116-x
Preciado L, Pereañez JA, Nuñez V, Lobo-Echeverri T. Characterization of the most promising fraction of Swietenia macrophylla active against myotoxic phospholipases A2: Identification of catechin as one of the active compounds. Vitae. 2016;23(2). DOI: http://dx.doi.org/10.17533/udea.vitae.v23n2a05
Romero-Estrada A, Maldonado-Magaña A, González-Christen J, Marquina-Bahena S, Garduño-Ramírez ML, Rodríguez-López V, et al. Anti-inflammatory and antioxidative effects of six pentacyclic triterpenes isolated from the Mexican copal resin of Bursera copallifera. BMC Complementary and Alternative Medicine. 2016;16:422. DOI: https://doi.org/10.1186/s12906-016-1397-1
Preciado Rojo LM, Rey Suarez P, Henao-Castañeda IC, Pereañez JA. Betulinic, oleanolic and ursolic acids inhibit the enzymatic and biological effects induced by a P-I snake venom metalloproteinase. Chemico-Biological Interactions. 2018;279:219–26. DOI: https://doi.org/10.1016/j.cbi.2017.12.001
Preciado LM, Pereañez JA, Azhagiya Singam ER, Comer J. Interactions between Triterpenes and a P-I Type Snake Venom Metalloproteinase: Molecular Simulations and Experiments. Toxins (Basel). 2018;10(10):397. DOI: https://doi.org/10.3390/toxins10100397
Pereañez JA, Núñez V, Huancahuire-Vega S, Marangoni S, Ponce-Soto LA. Biochemical and biological characterization of a PLA2 from crotoxin complex of Crotalus durissus cumanensis. Toxicon. 2009;53(5). DOI: https://doi.org/10.1016/j.toxicon.2009.01.021
Holzer M, Mackessy SP. An aqueous endpoint assay of snake venom phospholipase A2. Toxicon. 1996;34:1149–55. DOI: https://doi.org/10.1016/0041-0101(96)00057-8
Trott O, Olson A. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of computational chemistry. 2010;31(2):455–61. DOI: https://doi.org/10.1002/jcc.21334
Pettersen E, Goddard T, Huang C, Couch G, Greenblatt D, Meng E, et al. UCSF Chimera - a visualization system for exploratory research and analysis. Journal of computational chemistry. 2004;25(13):1605–12. DOI: https://doi.org/10.1002/jcc.20084
MolView. Available from: molview.org
Hanwell MD, Curtis DE, Lonie DC, Vandermeersch T, Zurek E, Hutchison GR. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. Journal of cheminformatics. 2012;4(17). DOI: https://doi.org/10.1186/1758-2946-4-17
Adasme MF, Linnemann KL, Bolz SN, Kaiser F, Salentin S, Haupt VJ, et al. PLIP 2021: expanding the scope of the protein–ligand interaction profiler to DNA and RNA. Nucleic Acids Research. 2021;49(W1). DOI: https://doi.org/10.1093/nar/gkab294
Pereañez Jimenez JA. Chapter 6 - Snake venom phospholipases A2 and their roles in snakebite envenomings. In: Phospholipases in Physiology and Pathology. Sajal Chakraborti. Academic press; 2023. p. 105–23. DOI: https://doi.org/10.1016/C2021-1-02265-9
Castro-Amorim J, Novo de Oliveira A, Da Silva SL, Soares AM, Mukherjee AK, Ramos MJ, et al. Catalytically active snake venom PLA2 Enzymes: An overview of its elusive mechanisms of reaction. Journal of Medicinal Chemistry. 2023;66:5364–76. DOI: https://doi.org/10.1021/acs.jmedchem.3c00097
Berg OG, Gelb MH, Tsai MD, Jain MK. Interfacial Enzymology: The Secreted Phospholipase A2-Paradigm. Chemical reviews. 2001;101(9):2313–54. DOI: https://doi.org/10.1021/cr990139w
Dharmappa KK, Kumar RV, Nataraju A, Mohamed R, Shivaprasad HV, Vishwanath BS. Anti-Inflammatory Activity of Oleanolic Acid by Inhibition of Secretory Phospholipase A2. Planta Med. 2009;75:211–5. DOI: https://doi.org/10.1055/s-0028-1088374
Nataraju A, Gowda CDR, Rajesh R, Vishwanath BS. Group IIA Secretory PLA2 Inhibition by Ursolic Acid: A Potent Anti- Inflammatory Molecule. Current Topics in Medicinal Chemistry. 2007;7:801–9. DOI: https://doi.org/10.2174/156802607780487696
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Laura Cardona-Alzate, Lina Maria Preciado-Rojo, Isabela Barahona-Sanchez, Vanesa Cardona-Cartagena, Jaime Andres Pereañez
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright Notice and Open Access Statement
The Journal Vitae works under the Open Access license, and the published manuscripts remain available for the public, both on the Journal's website and in databases, under the Creative Commons license, "Noncommercial Attribution" and "Share alike" systems, adopted in Colombia. Hence, when the authors agree to publish in the Journal Vitae, they will not have the right to economic retributions on publications and reproductions through different diffusion media. The documents are freely available to the internet public, permitting users to read, download, copy, distribute, print, search, or link to the full texts and pass them as data to software. The only constraint on reproduction and distribution, should be to give authors control over the integrity of their work and the right to be appropriately acknowledged and cited.
Authors declare that:
-
They are the intellectual property owners and are responsible for all the information stated in the article.
-
This manuscript has not been submitted or published in other printed or digital media. They accept the responsibility for the judgments, opinions, and points of view expressed in the published article and, therefore, they exonerate Universidad de Antioquia and Journal Vitae from any process.
-
They exempt Universidad de Antioquia and Journal Vitae from settling conflicts or disputes related to the authorship of the referred article.
-
They accept the revision of the original manuscript by suitable personnel, and they bind themselves to perform the corrections appointed or suggested by the assessors.
-
Therefore, they know the editorial process and will not bind the Editorial Board of the Journal to assume any obligations regarding the volume and issue in which the article is published.
-
They transfer the rights of publication, reprinting, and distribution of the article from the moment of its approval, in print and digital format, without the right to economic rewards, and under the licensing conditions considered relevant by Journal Vitae.
-
They fully authorize Universidad de Antioquia and Journal Vitae to submit the published material to the diverse databases and indexing systems where the Journal can be found to comply with the requirements of the regulatory authorities to maintain the national classification of journals.
-
They will assume the article publication costs established for the current issue, and they will make the payment as soon as they are informed about the volume and the issue in which the final version of the article is published.
-
After the article is published, you can share digital or printed copies in a noncommercial manner. You will be able to use the paper in your institution or company for educational or research purposes, including the use in course programs.
Conflict of interest: Authors are responsible for recognizing and disclosing any financial or other benefits that could be perceived to bias their work, acknowledging all financial support and any personal connections with potential sponsors. Examples of such conflicts include receiving research funds or honoraria, serving on advisory boards, stock ownership, or employment and consulting arrangements. Authors without such connections should clearly state that they have no financial support or personal relationships that could be perceived to bias their work. All conflicts of interest should be disclosed on the author's identification page of the manuscript.
